Physician

Abdullah Panchbhaya, MD

According to 2025 Medicare claims, Abdullah Panchbhaya, MD (NPI: 1528683513) practices family practice in the Rochester, NY market, with the plurality of this provider's patient population coming from Monroe, NY. This provider's primary affiliated billing organization is ROCHESTER GENERAL HOSPITAL (NPI: 1861568594; TIN: 237221763) and primary practice location at 14621-2006. Panchbhaya is affiliated with the Rochester Regional Health ACO, Inc. (ACO ID: A3476), participating under the MSSP model.

Panchbhaya's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 105 traditional Medicare patients, billed 243 HCPCS/CPT codes, and received $11,149 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 5,205 prescription claims across 846 beneficiaries totaling $531,857 in drug costs, led by Ozempic (Semaglutide). 2023 DME data shows 33 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $2,825 to $531,857. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$5.6K$11K2023 Medicare payment: $2,698 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $11,149 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
20232235$2,698
2024105243$11,149

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$266K$532K2020 Drug cost: $2,825 (USD; Tot_Drug_Cst)2021 Drug cost: $6,422 (USD; Tot_Drug_Cst)2022 Drug cost: $40,005 (USD; Tot_Drug_Cst)2023 Drug cost: $68,672 (USD; Tot_Drug_Cst)2024 Drug cost: $531,857 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
20201229$2,825
202139117$6,422
202273402$40,005
2023165637$68,672
20248465,205$531,857

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$451$9022023 Medicare payment: $902 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/R33$902
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
G0439Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit1313$123
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more75108$60
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more2020$42
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's3237$11

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
OzempicSemaglutide693,418$97,496
JardianceEmpagliflozin382,686$52,392
EliquisApixaban482,193$44,028
RybelsusSemaglutide201,198$37,868
JanuviaSitagliptin Phosphate12970$17,354

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Abdullah Panchbhaya, MD?

Tedicare shows public-source Medicare data for Abdullah Panchbhaya, MD (NPI 1528683513), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abdullah Panchbhaya, MD have ACO affiliation data?

Abdullah Panchbhaya, MD is shown with ACO affiliation data for Rochester Regional Health ACO, Inc. (MSSP, ACO ID A3476).

What billing organization is linked to Abdullah Panchbhaya, MD?

Abdullah Panchbhaya, MD is linked to ROCHESTER GENERAL HOSPITAL (billing NPI 1861568594) in the available physician profile data.

Does Abdullah Panchbhaya, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.